Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Dabora MC, Klekotka P, Shen L, Skovronsky DM, Investigators B (2021) Bamlanivimab plus Etesevimab in mild or moderate Covid-19. N Engl J Med 385(15):1382–1392. https://doi.org/10.1056/NEJMoa2102685
CAS
CrossRef
PubMed
Google Scholar
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E, Awake Prone Positioning Meta-Trial G (2021) Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med 9(12):1387–1395. https://doi.org/10.1016/S2213-2600(21)00356-8
CAS
CrossRef
PubMed
PubMed Central
Google Scholar
Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8–27. https://doi.org/10.1097/00005650-199801000-00004
CAS
CrossRef
PubMed
Google Scholar
Günster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, Weber-Carstens S, Schuppert A, Karagiannidis C (2021) 6-month mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. Plos One 16(8):e255427. https://doi.org/10.1371/journal.pone.0255427
CAS
CrossRef
PubMed
PubMed Central
Google Scholar
Hentschker C, Mostert C, Klauber J, Malzahn J, Scheller-Kreinsen D, Schillinger G, Karagiannidis C, Busse R (2021) Structure of hospital care for COVID-19 patients up to July 2020 in Germany. Med Klin Intensivmed Notfmed 116(5):431–439. https://doi.org/10.1007/s00063-021-00776-6
CAS
CrossRef
PubMed
PubMed Central
Google Scholar
Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, Klauber J, Janssens U, Marx G, Weber-Carstens S, Kluge S, Pfeifer M, Grabenhenrich L, Welte T, Busse R (2020) Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 8(9):853–862. https://doi.org/10.1016/S2213-2600(20)30316-7
CAS
CrossRef
PubMed
PubMed Central
Google Scholar
Karagiannidis C, Windisch W, McAuley DF, Welte T, Busse R (2021) Major differences in ICU admissions during the first and second COVID-19 wave in Germany. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(21)00101-6
CrossRef
PubMed
PubMed Central
Google Scholar
Kluge S, Janssens U, Welte T, Weber-Carstens S, Schalte G, Spinner CD, Malin JJ, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Bottiger BW, Weinmann-Menke J, Kersten A, Berlit P, Haase R, Marx G, Karagiannidis C (2021a) S2k Guideline – recommendations for inpatient therapy of patients with COVID-19. Pneumologie 75(2):88–112. https://doi.org/10.1055/a-1334-1925
CAS
CrossRef
PubMed
Google Scholar
Kluge S, Malin JJ, Fichtner F, Muller OJ, Skoetz N, Karagiannidis C (2021b) Clinical practice guideline: recommendations on the in-hospital treatment of patients with COVID-19. Dtsch Arztebl Int. https://doi.org/10.3238/arztebl.m2021.0374 (Forthcoming)
CrossRef
PubMed
PubMed Central
Google Scholar
Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schalte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Bottiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S (2021) Key summary of German national treatment guidance for hospitalized COVID-19 patients key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection. https://doi.org/10.1007/s15010-021-01645-2
CrossRef
PubMed
PubMed Central
Google Scholar
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW, Group C-BS (2021) Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med 9(12):1407–1418. https://doi.org/10.1016/S2213-2600(21)00331-3
CAS
CrossRef
PubMed
PubMed Central
Google Scholar
Mostert C, Hentschker C, Scheller-Kreinsen D, Günster C, Malzahn J, Klauber K (2021) Auswirkungen der Covid-19-Pandemie auf die Krankenhausleistungen im Jahr 2020. In: Klauber J, Wasem J, Beivers A, Mostert C (Hrsg) Krankenhaus-Report 2021; Schwerpunkt: Versorgungsketten – Der Patient im Mittelpunkt. Springer, Berlin, S 277–306
CrossRef
Google Scholar
RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384(8):693–704. https://doi.org/10.1056/NEJMoa2021436
CrossRef
Google Scholar
RECOVERY Collaborative Group (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397(10285):1637–1645. https://doi.org/10.1016/S0140-6736(21)00676-0
CrossRef
Google Scholar